Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.76 USD | +5.31% | +1.71% | -29.97% |
Apr. 09 | Synaptogenix, Inc. acquired Unknown Stake in Psyga Bio Ltd from Cannasoul Analytics Ltd. | CI |
Apr. 03 | Synaptogenix Plans 1-for-25 Reverse Stock Split; Shares Fall | MT |
Business Summary
Number of employees: 5
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 17-12-31 |
Daniel Alkon
PSD | President | 81 | 20-12-06 |
Robert Weinstein
DFI | Director of Finance/CFO | 64 | 13-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 17-12-31 |
Bruce Bernstein
BRD | Director/Board Member | 60 | 16-11-13 |
Joshua Silverman
CHM | Chairman | 53 | 16-08-03 |
Director/Board Member | 50 | 18-12-12 | |
William Singer
BRD | Director/Board Member | 82 | 13-08-22 |
Daniel Alkon
PSD | President | 81 | 20-12-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,085,333 | 1,058,910 ( 97.57 %) | 0 | 97.57 % |
Stock B | 0 | 6,000 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-29.97% | 5.17M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+49.67% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- SNPX Stock
- Company Synaptogenix, Inc.